Sera from patients with disease caused by the Mycobacterium avium complex (M. avium and M. intracellulare), M. kansasii, or M. tuberculosis and from subjects who did not have a mycobacterial disease were tested by enzyme-linked immunosorbent assay against peptidoglycolipid antigens representing each of the 15 most common serovars of the M. avium complex and against crude protein antigen extracts of M. avium and M. tuberculosis. The highly specific peptidoglycolipid antigens yielded positive reactions in 83% of M. avium complex patients, 57% of active-tuberculosis patients, and 14% of subjects without mycobacterial disease. Reactions to more than 1 of the 15 peptidoglycolipid antigens were found only in patients with infections caused by mycobacteria, suggesting that a mycobacterial pulmonary lesion is readily colonized by mycobacteria other than the one that initiated the lesion. The two crude mycobacterial protein antigens were highly cross-reactive, with little if any capacity to discriminate between infections caused by any of the mycobacteria studied. Moreover, they did not appear to be more sensitive than the peptidoglycolipids. The data suggest that it is unlikely that a practical and reliable serological test can be developed that will distinguish between transient subclinical infection and significant disease caused by common environmental mycobacteria, such as members of the M. avium complex. Success in developing such a test for nonenvironmental mycobacteria, such as M. tuberculosis, appears more likely.
The search for a satisfactory serological test for tuberculosis and other mycobacterial diseases presents a difficult challenge in balancing sensitivity against specificity (14) . Proteins of most species of mycobacteria, both environmental opportunists and strict pathogens, share many epitopes (5, 6, 8) . For example, antibodies to the T class of catalase from one mycobacterial species cross-react by different degrees with T catalase from every other mycobacterial species that produces that enzyme, and the same holds true for M catalase (19) . However, cross absorption of sera yields antibodies that react only with the catalase of members of the homnologous species (20, 21) , thus proving the presence of both epitopes that are species specific and epitopes that are common to the other members of the genus, all on the same molecule. Hewitt and colleagues (11) used monoclonal antibodies to demonstrate epitopes that were unique to proteins of Mycobacterium tuberculosis; some were so specific as to be absent in some strains of that species. Other epitopes were common to two or more species but not to all strains of a reactive species. The application of a monoclonal antibody in competitive assays to detect antibody in sera of human subjects yielded positive results in only 74% of patients with culturally proven active tuberculosis (13) .
In contrast to the serologic cross-reactivity of mycobacterial proteins, a very high degree of specificity exists in the unbound surface peptidoglycolipids and other glycolipids that are responsible for the infrasubspecific serovar agglutination classification of a number of mycobacterial species (1, 2, 15) . For example, strains of M. avium, M. intracellulare, and M. scrofulaceum all produce a surface antigen with a common peptidoglycolipid core, and the specificity of the 30 or more serovars within the serocomplex is determined by the composition of the oligosaccharide linked at a defined point on that core (1, 2) . Dawson and colleagues (9) demon-* Corresponding author. strated the presence of serovar-specific agglutinating antibody to members of the M. avium complex in the sera of five patients from whom the organisms were isolated. Wayne and colleagues (23) demonstrated specific antibody against purified serovar-specific peptidoglycolipid antigen by enzymelinked immunosorbent assay (ELISA) in sera from a small series of patients with pulmonary infection caused by M. avium complex but not in sera of acquired immunodeficiency syndrome patients with proven disseminated M. avium complex infections. M. leprae produces a unique phenolic glycolipid surface antigen that has been exploited in the development of a sensitive and specific serological test for leprosy (7) .
Many evaluation studies of serological tests for tuberculosis used as controls sera from subjects who either were healthy or had some nonmycobacterial disease. It was the purpose of the present study to compare results of serological testing of sera from populations with different mycobacterial diseases with results of sera from patients with nonmycobacterial pulmonary and nonpulmonary disease, as well as healthy controls, using both relatively nonspecific crude protein antigens and purified highly specific peptidoglycolipid antigens. Although neither of these two types of antigens proved to be of sufficient diagnostic value to be adopted for routine testing of clinical materials, the results of the study provide some insights into the natural history of mycobacterial infection.
MATERIALS AND METHODS
Serologic reference materials. Rabbit antisera to each of the agglutinating serovars of M. avium and M. intracellulare were provided by Anna Tsang, National Jewish Hospital and Research Center, Denver, Colo., with support from the United States-Japan Cooperative Medical Sciences Program. The M. avium complex comprises the two species M. aviun and M. intracellulare, and each of these species comprises 10 or more agglutinating serovars (21) . Selected strains of each of the desired serovars to be used for preparation of polar peptidoglycolipid antigens were provided by Robert C. Good, Centers for Disease Control, Atlanta, Ga.
Human sera. Sera from patients with different diseases (see footnote to Table 1 ) were obtained at this medical center. Some additional sera from patients with M. avium complex infections were also provided through the courtesy of Bonnie Lutz, Orange County Health Department, Santa Ana, Calif., and David Salkin, La Vina Sanatorium, Altadena, Calif. Sera from healthy blood donors and information on ages of the donors were provided by Harold Kaplan and Arell Shapiro, Orange County Chapter of the American Red Cross. The diagnosis of disease caused by mycobacteria other than M. tuberculosis was based on clinical signs and symptoms compatible with those infections, with more than one isolation of the mycobacterial agent and no isolations of M. tuberculosis from the patients' specimens.
Preparation of polar peptidoglycolipid antigens. Strains of M. avium and M. intracellulare representing each of the 15 serovars to be tested were grown for 2 to 3 weeks on Dubos oleic albumin agar. The bacilli were harvested and washed twice in distilled water, and the volume of packed cells was recorded. The extraction procedure was based on methods described by Brennan and colleagues (2, 3) . Volumes of reagents represented the amounts used per milliliter of packed bacilli. The cells were extracted overnight at room temperature in 12 ml of a 1:1 mixture of chloroform and methanol and centrifuged. The supernatant solution was removed, and the cells were re-extracted in 4 ml of 1:1 chloroform-methanol. The two supernatant extracts were combined, and the pooled solution was resolved into two phases with 2.0 ml of phosphate-buffered saline, pH 7.5. The aqueous-methanol phase was discarded, and the chloroform phase was removed from any solid residue that formed and taken to dryness at 50°C in a stream of nitrogen. The residual solid was taken up in 5 ml of dry chloroform and centrifuged to remove insoluble residue. The chloroform was evaporated to dryness, and the residue was taken up in 5 ml of dry methanol and centrifuged. Chloroform (10 ml) was added to the methanol extract, and the solution was warmed to 37°C. The antigens were deacetylated by adding 15 ml of prewarmed 0.2 M NaOH in methanol and incubating at 37°C for 20 min, and the hydrolysis was stopped with 0.375 ml of glacial acetic acid. Normal saline (12 ml) was added to break the solution into two phases. The chloroform phase was withdrawn, washed with 2.5 ml of normal saline, and taken to dryness as before. The dried solute was extracted with hexane at 50°C for 30 min to remove nonpolar pëptidogly-colipid, and the hexane-insoluble residue, which comprised the desired polar peptidoglycôlipid antigen, was dissolved in 5 ml of absolute ethanol. Samples were assayed for sugar content by the method of Dubois et al. (10) For tests with crude protein antigens, the wells were primed by the addition of 20 ,ul of a solution containing 100 pug of the desired protein per ml and 100 ,ul of 0.05 M bicarbonate buffer (pH 9.4) and held at room temperature overnight. The wells were then aspirated and blocked by the same procedure as used for the peptidoglycolipid-primed plates described above.
For the surveys of human sera against either protein or peptidoglycolipid antigens, 100 ,ul of a 1:100 dilution of human serum was dispensed to wells coated with each of the selected antigens and to a blocked well without antigen and incubated at room temperature for 2 h. The serum was then aspirated, and the wells were washed three times with a solution of 0.05% Tween 20 in normal saline (Tween-saline) and once in plain saline.
The second antibody, alkaline phosphatase-conjugated goat anti-human immunoglobulin G (or anti-rabbit immunoglobulin G, for standardization of reagents against specific rabbit sera) ( 
RESULTS
The human sera were classified according to the categories of subjects from whom they were obtained (see footnote to Table 1 ). Sera from a total of 107 subjects were tested by ELISA against peptidoglycolipid antigens extracted from strains representing the 15 most frequently encountered serovars of the M. avium complex, i.e., 1, 2, 4, 6, 7, 8, 9, 10, 12, 13, 14, 16, 18, 19, and 25 (15) . Several sera were tested repeatedly, both to assess reproducibility of response and to serve as positive and negative controls for survey plates. Means and standard deviations of replicates of raw data are presented for selected serum specimens in Fig. 1 and demonstrate satisfactory reproducibility of the assay system. The extent of nonspecific background binding of immunoglobulin varied markedly from serum to serum, but specific reaction peaks were evident. For example, the mean A405 values of eight replications of serum 20 (Fig. 1A ) against all 15 antigens and in the antigen-free background well were all below 0.10 and within one standard deviation of one another. In contrast, the mean A405 values of eight replications of serum 55, from a patient with M. avium complex infection (Fig. 1C) , were high and variable for the different antigen wells. This did not appear to represent cross-reaction to different antigens but rather some nonspecific adherence of the immunoglobulin to the plastic or the blocking albumin, since the mean A405 for the antigen-free well was higher than that for those containing antigens of 11 of the serovars. A similarly high antigen-free background absorbance was seen with serum 74, from another M. avium complex patient (Fig.  1D) ; whereas serum 61, from a third M. avium complex patient (Fig. 1B) , yielded a mean antigen-free well A405 almost identical to those in 14 of the antigen wells. All three of the sera from M. avium complex patients shown in Fig. 1 gave peak reactions to serovar 8, but serum 55 (Fig. 1C) also showed peaks to serovar 7, whereas serum 74 (Fig. 1D ) also peaked with serovars 4 and 10. These cases appear to represent multiple specificities rather than cross-reactions, since each serum gave a different pattern, even though all three reacted to serovar 8.
As noted above, there was considerable variation in nonspecific adherence of the immunoglobulins from serum to serum, and the antigen-free well did not always yield the lowest score to serve as a background reading for some of the specimens. For this reason, the following formula was adopted for recording the ELISA score (£A) for each peptidoglycolipid antigen: AA = Ar -M, where Ar is the raw A405 in a given antigen well and M is the mean A405 for all 15 of the antigen-containing wells in a given serum row. The highest AA score seen with each serum against the 15 peptidoglycolipid antigens was recorded as SAmax and the distribution of £Amax scores was plotted for each of the human subject categories (Fig. 2) .
The highest scores against one or more of the 15 serovarspecific peptidoglycolipid antigens of the M. avium complex were seen with sera from patients with pulmonary disease caused by members of the M. avium complex (MAC); the difference in score distribution was statistically significant compared with that of all other categories of human subjects (P < 0.05 compared with sera from the active-tuberculosis patients [TBA]; P < 0.025 compared with all other categories). The second highest score distribution was seen with sera from patients with TBA, and here also the difference in score distribution was significant when compared with all other categories (P < 0.025 compared with sera from cardiac disease patients [CAR]; P < 0.01 compared with all other categories). The differences in A£max distributions among the remaining four subject categories, inactive-tuberculosis patients (TBX), M. kansasii patients (MKA), chronic obstructive pulmonary disease patients (COP), and healthy blood donors (NOR), were not statistically significant (P- 0.05). However, inspection of Fig. 2 suggests that the score distribution in the MKA group is higher than those from any of the subjects who did not have known mycobacterial disease and that the lack of statistical significance may be a function of the small number of subjects in this category.
If the reaction of a given serum in the peptidoglycolipid ELISA is interpreted as positive for those antigens for which the AA was .0.20, then 85% of the MAC sera, 57% of the TBA sera, 50% of the MKA sera, and 30% of the TBX sera were positive against one or more of the 15 peptidoglycolipid antigens tested, and fewer than 20% of any of the other sera exceeded that threshold (COP, 18%; CAR, 14%; NOR, 8%).
The distribution of all positive reactions (AA, -0.20) according to subject category and serovar is presented in Table 1 group were over 65 years of age. When the comparison of CAR and COP subjects was restricted to subjects who were over 65 years of age, the difference in distribution of A4max scores between these two control groups was not significant (P > 0.05); however, the scores of COP subjects who were under 65 years old were significantly lower than those of COP subjects who were older (P < 0.05), but a comparable age-related distinction could not be demonstrated in the CAR group.
Crude protein antigens from M. tuberculosis and M. avium in ELISA showed little if any discrimination between sera from patients with active disease caused by M. tuberculosis and M. avium complex, as reflected by the fines of regression comparing these antigens against sera from each of these two human subject categories (Fig. 3) .
The distribution of ELISA scores was plotted for these two antigens for all human subject categories (Fig. 4) ranging from <0.0001 to <0.05 in all cases), regardless of which of the two crude protein antigens was used. Furthermore, sera from subjects with no known mycobacterial disease but with £Amax scores of >0.20 against a peptidoglycolipid surface antigen did not exhibit significantly higher scores against the crude protein antigens than those of sera from subjects with no known mycobacterial disease that gave low £Amax scores against all peptidoglycolipids tested.
DISCUSSION
The peptidoglycolipid surface antigens from the M. avium complex were selected for this study because of their striking specificity, whereas the crude protein extracts of M. avium and M. tuberculosis were used to present the maximum number of different mycobacterial epitopes to the antibodies with the intent of favoring sensitivity. As seen in Fig. 2 (15). Furthermore, 56% of the patients with pulmonary disease caused by mycobacteria other than members of the M. avium complex, i.e., the combined TBA and MKA groups, yielded àAmax scores above 0.20, whereas only 14% of the subjects who had no known mycobacterial disease, i.e., the combined COP, CAR, and NOR groups, gave scores above this threshold with peptidoglycolipid antigens. It is of special interest that over half of the patients infected with M. tuberculosis or M. kansasii, neither of which produces the peptidoglycolipid antigens of the M. avium complex, displayed significant levels of antibody to one or more of these antigens. Tsukamura and colleagues (18) reported the isolation of members of the M. avium complex in mixed culture from more than 10% of sputum specimens that yielded M. tuberculosis. They speculated that coinfection may occur at the time of primary infection, but it appears equally likely that these ubiquitous organisms colonize pulmonary cavities that result from initial infection with M. tuberculosis.
The appearance of positive reactions to peptidoglycolipid J. CLIN. MICROBIOL. antigens representing two or more different serovars in the sera of a number of patients with known pulmonary mycobacterial disease but not of any of the subjects without mycobacterial disease, or of any patients whose tuberculosis had been inactive for 2 or more years (Table 1) , supports the interpretation that many of these reactions were a consequence of exogenous reinfection of a "prepared" site. The occurrence of a positive reaction to a single peptidoglycolipid antigen in sera from 14% of human subjects with no history of mycobacterial disease is consistent with transient subclinical infection by these organisms from the environment. Palmer and Edwards (16) reported sensitization to a skin test antigen prepared from a member of the M. avium complex in proportions ranging from <20 to >70% of U.S. Navy recruits, depending on their geographic region of origin. The low levels of antibody to any of the mycobacterial antigens in our ELISAs of most of the sera from subjects whose tuberculosis had been inactive for 2 years or more suggest that the serologic B-cell response is of shorter duration than the T-cell response associated with the skin test, in agreement with observations of Huygen and colleagues (12), who used purified protein derivative and a 32-kilodalton protein.
When crude protein extracts were used as antigens, there was no practical difference between proportional responses to proteins from M. tuberculosis and M. avium, regardless of which organism was responsible for the subjects' disease (Fig. 4) . Although these extracts contained innumerable epitopes associated with a multiplicity of proteins, the distribution of positive responses (i.e., ELISA scores above the selected threshold A405 of 0.20) for the subjects who did not have mycobacterial diseases (CAR, COP, and NOR) was comparable to that seen when only the 15 highly defined small epitopes on peptidoglycolipid antigens were offered. The tuberculosis patients showed a small increase in numbers of positive results when crude protein was used instead of peptidoglycolipid antigen, presumably accounting for subjects who were infected with M. tuberculosis but not superinfected with a member of the M. avium complex.
The data presented here allow some inferences to be drawn about the prospects of developing useful immunologic tests for diagnosis of mycobacterial diseases. The positive serologic responses to peptidoglycolipid antigens representing single serovars of the M. avium complex by many human subjects who had no demonstrable disease caused by a member of that complex do not suggest a lack of specificity in terms of ability to recognize very specific, well-defined mycobacterial epitopes. Rather, they are evidence of a lack of serologic discrimination between transient infection and significant disease caused by opportunistic environmental mycobacteria, such as those of the M. avium complex. This conclusion is supported by the similarity in distributions of ELISA scores among subjects without 
